TransMedics Group Inc (FRA:8T8)
€ 75.94 1.86 (2.51%) Market Cap: 2.56 Bil Enterprise Value: 2.73 Bil PE Ratio: 90.32 PB Ratio: 13.57 GF Score: 76/100

Transmedics Group Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 12:30PM GMT
K. Gong
JPMorgan Chase & Co, Research Division - Associate

Okay. Good morning, everyone, and welcome to Wednesday of the JPMorgan Healthcare Conference. My name is Allen Gong. I'm on the medical supplies and devices team here at JPMorgan, and it is my pleasure to introduce the management team of TransMedics.

Leading the remarks today will be President and CEO, Waleed Hassanein. And then joining us for the Q&A will be CFO, Stephen Gordon. (Operator Instructions)

With that, I will leave it to Waleed.

Waleed H. Hassanein
TransMedics Group, Inc. - Founder, MD, CEO, President & Director

Thank you, Allen. Good morning, everybody. Thank you to Allen and the JPMorgan team for the opportunity to present at the conference this year.

Slide #2 shows our forward-looking statement.

Jumping into Slide 3, what does TransMedics do? TransMedics is transforming one of the most important and exciting fields and therapies in medicine, which is solid organ transplant. And we'll explain to you why this is very important and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot